Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am with you on gold shining again fitz
These are top-10 global mining trends expected for 2018
http://www.mining.com/top-10-global-mining-trends-expected-2018/?utm_source=digest-en-mining-180131&utm_medium=email&utm_campaign=digest
Bidders for $500m Canada streaming deal as cobalt price surges–report
http://www.mining.com/bidders-500m-canada-streaming-deal-cobalt-price-surges-report/?utm_source=digest-en-mining-180130&utm_medium=email&utm_campaign=digest
CHART: Hedge funds have never been this bullish about oil
http://www.mining.com/chart-hedge-funds-never-bullish-oil/?utm_source=digest-en-mining-180129&utm_medium=email&utm_campaign=digest
$AMRS, watcher, fill the gap? Volume increase last few days, minus yesterday
http://stockcharts.com/h-sc/ui?s=AMRS&p=D&yr=1&mn=0&dy=0&id=p77350746957
Great call buddy, $HAON 0.0007 0.00 0.00 1,000,000 0.0006 0.0007
Alerted @ 1.03, Upward slowly $APHB 1.1748 0.0848 +7.78 569,925 1.17 1.18
Don't apologize for nothing buddy, We made money twice so far.
Thanks for the updates!
My play is for food.
Food production is very energy intensive in production and shipping. Gasoline is 31% higher than 1 year ago.
https://www.finviz.com/futures_charts.ashx?p=d1&t=RB
The dollar is 10% lower than a year ago. It is 10% cheaper for other countries whose currencies are 10% higher than last year to import US food.
https://www.finviz.com/futures_charts.ashx?p=d1&t=DX
RJA, a food commodities unleveraged fund is 10% lower than last year. Bumper crops, but I believe a bottom is in and overdone. The crop surplusses are not much different than last year and assuming the dollar and gasoline stay where thery are all year, no way does RJA stay this low.
All just opinion. I have owned from higher but did just add nice chunk. No my largest holding.
http://stockcharts.com/h-sc/ui?s=RJA&p=D&yr=1&mn=0&dy=0&id=p49560099375
Let me add, the Nasdaq fell 66% in the 2 and 1/2 year Bear from March 2000 til October 2002. I checked out a basket of food stocks and they were up 5%(2% per year} in that same period, plus dividends, minus brokerage fees. Food is noprmall a safe haven in Bear markets.
As I can't send PM on here, I apologise for including my OTC stock. ONCI has been beat down for a while now. CEO just tweeted a message about TomTom without explaining why. After a little digging, it seems that while TomTom's FLEETWEB is HUGE in Europe and Asia (and was voted one of the best five Apps for Fleet Management Services in Europe) , the TomTom Fleet Business is non-existent here in the US. Just guessing but who knows. Hopefully, this week, Steve Berman will expand why he sent-out this tweet about TomTom's 3rd Quarter Results:
http://files.shareholder.com/downloads/TOMTOM/5865437243x0x960344/234D4F91-EEC2-41A4-B6B0-DF6834EB3409/TomTom_Q3_2017_results_press_release.pdf
And most people thought TomTom had been dead for quite sometime. They are on the cutting edge working with many of the largest Auto Manufacturers on autonomous driving cars.
Just keep your peepers open as this may be a good time to watch or invest. All in my own opinion as that's all I have. Have a great and warm MLK Weekend.
Too old to rock and roll, too young to die
Jethro Tull-Too old to rock'n' roll
https://www.youtube.com/watch?v=ZK4V5vg32ho
Got a date? lol
$TANH Marble, Granite sector can be transformed into cutting-edge stone industry
Chart>>
http://stockcharts.com/h-sc/ui?s=TANH&p=D&yr=1&mn=0&dy=0&id=p97537234251
https://pakobserver.net/marble-granite-sector-can-transformed-cutting-edge-stone-industry/
Marble and Granite industry of Pakistan can be transformed into a cutting-edge stone industry by adopting Chinese quarrying techniques.
It was observed by S.M. Naveed, President Pak China Joint Chamber of Commerce and Industry during a meeting with Wang Zihai, Chairman PCJCCI China affairs. He pointed out that export quantum of marble and granite can be increased many folds by establishing marble Industrial parks in collaboration with China under CPEC to effectively utilize the valuable marble reserves of the country.
S.M. Naveed said that Industrial Parks will bring the cost effective cutting, blasting and finishing technology in Pakistan that will enhance the competitive edge of the industry. He told that all provinces in Pakistan had huge deposits of ornamental stones.Baluchistan has rich confirmed deposits of marble and granite in Khuzdar, Loralai, Lasbela and Chaghi districts, whereas in Khyber Pakhtunkhwa, Malakand, Mardan, Hazara, Peshawar and Kohat are the high-potential areas where quarrying and mining is already taking place, he added.
Identifying the major factors hindering the growth of Marble Industry in the country, he said the lack of quality production, inconsistent supply of raw material and scarcity of the modern technology were the factors, which needed government attention. He suggested to strengthen Pakistan Stone Development Company (PASDEC) to fill in the missing chains in marble industry. He told that the extraction in Pakistan mainly comprise boring of holes in the bedrock, filled with explosives to blast the block, resulting not only in high wastage but also in smaller sized stone, substantially reducing the price. He informed that standard quarry wastage in the world is taken at 50% of the gross produce; however, in Pakistan this reaches up to 73%. According to S.M.Naveed, Wastage can be avoided by using latest wire-cutting technique and equipment, thus bright prospects of setting up joint ventures in the Marble Sector exist in Pakistan.
Escalating further about the policies and exemptions given by the Pakistani government to investors, S.M. Naveed told that Pakistani Government had abolished import duties on all quarrying and processing machinery to facilitate foreign investment, which is very encouraging and the local business community should upgrade their units by availing of this facility.
He said, global market for marble and granite was estimated at around $62 billion, but Pakistan’s share was below one percent, which is a cause of concern for the policymakers. He said with the support of government, marble industry has the potential to become the backbone of the economy and promote more exports than the share of textile products and urged that government should address marble industry issues on priority.
Mr. Wang Pledged to share this valuable information with the relevant counterparts in China. He said that he will discuss the proposal for transferring Marble Extraction technology from China to Pakistan that will be beneficial for both countries. Both Mr. Wang and S.M. Naveed jolted down multiple proposals for promoting model quarries / mining projects in line with the best international practices and the latest technology
BDR bid ask up after hours. Too bad I won't be around at the open to see what's up
http://stockcharts.com/h-sc/ui?s=BDR&p=D&yr=1&mn=0&dy=0&id=p74767562151
Nice call, $HMNY 8.89 1.73 +24.16 9,347,954 8.84 8.86
I got to sit tight. I am getting bad vibes here on the overall market. Usually this should be taken as a strong buy of anything, lol.
A lot of little stocks are getting hammered.
Recent negative stories>>>>
http://theeconomiccollapseblog.com/archives/study-finds-that-22-percent-of-bitcoin-investors-are-using-debt-to-fund-their-investments
https://www.ft.com/content/0b83e9ca-f4c5-11e7-88f7-5465a6ce1a00
Junior Lithium Miners See Big Upside As China Moves To Secure Lithium Supplies
https://streetsignals.com/standard-lithium/sll-9/junior-lithium-miners-see-big-upside-as-china-moves-to-secure-lithium-supplies/?utm_source=facebook&utm_medium=paid_social&utm_campaign=facebook_SLL_Big-Upside_Quote-Pages_55-65-M-US-CA_auto-boost_c_300382
Better not knowing than knowing wrong? LOL
Honest answer, I'm not sure about anything right now. lol
Mining in 2018: Copper price to power on
http://www.mining.com/mining-2018-copper-price-power/?utm_source=digest-en-mining-180102&utm_medium=email&utm_campaign=digest
This market is spookier than ever. Tons of money made on little guy stocks. We have a riskier banking industry than in 2008. We had the internet boom of the late 90's. Now we have pot stocks and bit coin, plus comparable's. Nobody can prove to me that crypto currencies can't all go to ZERO by next week, what joke. This is the biggest market madness I have ever seen. Never so much euphoria, scary.
The 4 stocks I posted today, one doubled and fell back for loss, one a slight down after being up all day, one up 9% and one up 35%. This is nuts, but might stay nuts for a while.
Up over 100% since alerted, $PVCT 0.087 0.005 +6.10 1,250,627 0.085 0.087
IMO still moving to .28
$CHCI another #Homebuilder with 1.57M float per yahoo
http://stockcharts.com/h-sc/ui?s=CHCI&p=D&yr=1&mn=0&dy=0&id=p65286592647
$XNET 13 G 5.1% stake by $MS Friday
http://stockcharts.com/h-sc/ui?s=XNET&p=D&yr=1&mn=0&dy=0&id=p51858031371
lol, good night, have fun!
Got it running, scary, too fast, lol.
Got it running, scary, too fast, lol.
Get your new computer up and running?
DPWW, no more? Missed it, at work at the open.
$ADVT, just got out EOD
$ADVT 0.0193 0.0028 +16.97 4,141,224 0.019 0.0193
$DPWW $OWCP $GRCU $XXII
Charts of interest
http://stockcharts.com/h-sc/ui?s=DPWW&p=D&yr=1&mn=0&dy=0&id=p67064855110
http://stockcharts.com/h-sc/ui?s=OWCP&p=D&yr=1&mn=0&dy=0&id=p63776822556
http://stockcharts.com/h-sc/ui?s=GRCU&p=D&yr=1&mn=0&dy=0&id=p15442545060
http://stockcharts.com/h-sc/ui?s=XXII&p=D&yr=1&mn=0&dy=0&id=p73030427985
$PVCT,
Provectus News
First Study of Quality of Life of Patients with Locally Advanced Cutaneous Melanoma Published in Melanoma Research
- Emotional health/self-perception issues were most common; limitations of lifestyle and activities as well as coping strategies were also important -
- Provectus Biopharmaceuticals expands pivotal Phase 3 trial of intralesional PV-10 for this patient population to EU and LATAM; U.S. sites continue to enroll -
Wednesday December 27, 2017
KNOXVILLE, TN, /Globe Newswire/ -- Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com), ("Provectus" or the "Company"), a clinical-stage biotechnology company developing the first small molecule oncolytic immunotherapy for solid tumor cancers, today announced that Melanoma Research (the "Journal") published results from a Provectus-sponsored study to understand the daily experiences of patients with locally advanced cutaneous melanoma. Physical and emotional experiences, symptom management, and subsequent impacts on quality of life historically have not been well understood or sufficiently described for this patient population.
The article may be accessed via the Journal's website under Published Ahead-of-Print at http://journals.lww.com/melanomaresearch/Abstract/publishahead/Quality_of_life_patient_reported_outcomes_for.99332.aspx.
Interviews of adults with Stage IIIB, IIIC or IV M1a cutaneous melanoma at three cancer centers in the U.S. (Moffitt Cancer Center, Tampa, Florida and Huntsman Cancer Institute, Salt Lake City, Utah) and Australia (Melanoma Institute Australia, Sydney) were conducted to assess how locoregionally advanced cutaneous melanoma impacted everyday life. According to the Journal article, "[e]motional health/self-perception issues were the most commonly identified (41% of patient impact expressions), including worry, concern, embarrassment, self-consciousness, fear, and thoughts of death. Limitations of lifestyle and activities were also identified (28% of expressions) including leisure and social activities, physical functioning, general functioning, and personal care. Coping strategies such as modified clothing choices, increased use of pain and/or anti-inflammatory medications, and avoidance/protection from the sun represented 20% of all impact expressions."
Study investigators "collected information on disease-specific patient-reported assessment of symptoms and quality of life (patient-reported outcomes, or PROs) that may provide a basis for supporting the clinical significance of objective response parameters such as progression-free survival (PFS) and complete response."
The Journal article also noted that "oth the US Food and Drug Administration and the European Medicines Agency have highlighted the value of establishing content validity in the development of tools to assess patient-reported outcomes. Such PRO-geared tools can extract critical concepts and impacts pertinent to the patient experience. Focus groups and interview sessions can be among those tools to elicit the patient experience."
Provectus previously supported Stage III melanoma patient advocacy efforts by the Melanoma Research Foundation ("MRF"):
A focus group, which addressed initial diagnosis, treatment, disease progression and the need for self-education and support; a summary of this group's outcome is available on Provectus' website at http://provectusbio.com/media/docs/MRF_Stage_III_Focus_Group_Summary_BRIEF_FINAL.pdf, and
MRF's Stage III Melanoma Patient Guide, which may be found on MRF's website at https://www.melanoma.org/understand-melanoma/cutaneous-melanoma/stage-iii-melanoma.
In its Summary Basis of Regulatory Action for IMLYGIC®1, the first intralesional therapy approved for melanoma, the U.S. Food and Drug Administration ("FDA") noted that "patients and their caregivers spoke of the value, both cosmetic and psychological, of watching their skin lesions disappear" during the April 2015 Joint Meeting of the Cellular, Tissue and Gene Therapies Advisory Committee and Oncologic Drugs Advisory Committee. The FDA also noted "[t]here may be associated psychological benefit, which may be substantial in patients who can see their visible lesions recede."
For patients with locally advanced cutaneous melanoma, Provectus is evaluating intralesional PV-10 versus chemotherapy (dacarbazine or temozolomide) or oncolytic viral therapy (IMLYGIC) in an international, multi-center, pivotal Phase 3 trial (NCT02288897). In-transit, satellite and locally recurrent melanoma patients (Stage IIIB, IIIC or IV M1a) with at least one injectable lesion who are not candidates for treatment with either a checkpoint inhibitor or targeted therapy (with BRAF or combined BRAF/MEK inhibitors) are eligible. The trial's primary endpoint is PFS (assessed via RECIST 1.1 every 12 weeks up to 18 months); complete response rate and overall survival are key secondary endpoints. PV-10 currently is or soon will be available at 19 clinical sites in five countries. The study is enrolling in Germany, Italy and the U.S., and clinical trial authorizations have been received for France and Mexico.
More information about this Phase 3 trial is available via ClinicalTrials.gov, the registry of clinical trials run by the U.S. National Library of Medicine at the National Institutes of Health ("NIH"), at https://clinicaltrials.gov/ct2/show/study/NCT02288897?term=Provectus%2C+PV-10&rank=6&show_locs=Y#locn.
Dominic Rodrigues, Chairman of the Company's Board of Directors, said, "Provectus has had a longstanding commitment to understanding quality of life issues in order to better design our clinical trials. We believe the endpoints of our pivotal Phase 3 trial for locally advanced cutaneous melanoma, like progression-free survival and complete response rate, are congruent with the findings of this quality of life study that highlight patients' emotional and physical challenges, which owe to their persistent, visible disease."
Mr. Rodrigues added, "We are grateful to our regulatory partners at FDA, Therapeutic Goods Administration, Agenzia Italiana del Farmaco, Bundesinstitut für Arzneimittel und Medizinprodukte, Agence Nationale de Sécurité du Médicament et des Produits de Santé, and Comisión Federal para la Protección contra Riesgos Sanitarios for working with Provectus to achieve clinical trial authorization in their respective countries for this important trial, and to enable the Company to continue the drug development work required to advance delivery of accessible and affordable healthcare around the globe via PV-10, the first small molecule oncolytic immunotherapy for melanoma."
The complete press release is available at http://www.provectusbio.com/news/press-releases/provectus-pr-20171227-1 on the Provectus
How did you know? LOL
My plan is to retire this computer in a few minutes and get my new one ready. My back up plan is to not keep this one not too far away, just in case, lol. And besides that, my back up plan is to not keep this one not too far away, just in case, lol.
LOL, wish I owned it.
DEWM 0.0059 0.001 +20.41 16,063,926 0.0058 0.0059
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |